143 related articles for article (PubMed ID: 2925176)
1. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant.
Radaszkiewicz T; Hansmann ML; Lennert K
Histopathology; 1989 Jan; 14(1):11-24. PubMed ID: 2925176
[TBL] [Abstract][Full Text] [Related]
2. Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients.
Kojima M; Nakamura S; Motoori T; Shimano S; Murayama K; Tamaki Y; Shimizu K; Oyama T; Sugihara S; Sakata N; Masawa N
APMIS; 2002 Dec; 110(12):875-80. PubMed ID: 12645666
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
4. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: a case report with immunohistochemical study].
Dworák O; Tschubel K; Zhou H; Meybehm M
Klin Wochenschr; 1988 Jul; 66(13):591-5. PubMed ID: 3210655
[TBL] [Abstract][Full Text] [Related]
5. Pathohistological and immunohistochemical studies on Castleman's disease of the lymph node.
Nagai K; Sato I; Shimoyama N
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):287-97. PubMed ID: 3087057
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell variant of Castleman's disease localized to the liver: a case report.
Mosnier JF; Fléjou JF; Degos F; Belghiti J; Brouet JC; Benhamou JP; Degott C
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):169-72. PubMed ID: 8723423
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K
Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184
[TBL] [Abstract][Full Text] [Related]
8. An immunohistological and genotypic study of the plasma cell form of Castleman's disease.
Hall PA; Donaghy M; Cotter FE; Stansfeld AG; Levison DA
Histopathology; 1989 Apr; 14(4):333-46; discussion 429-32. PubMed ID: 2737612
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.
Ogoshi T; Kido T; Yatera K; Oda K; Kawanami T; Ishimoto H; Sakamoto N; Sano A; Yoshii C; Shimajiri S; Mukae H
Lung; 2013 Dec; 191(6):575-83. PubMed ID: 23942842
[TBL] [Abstract][Full Text] [Related]
10. Castleman's disease associated with pemphigus vulgaris.
Gili A; Ngan BY; Lester R
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):955-9. PubMed ID: 1761779
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.
Gould SJ; Diss T; Isaacson PG
Histopathology; 1990 Aug; 17(2):135-40. PubMed ID: 2227838
[TBL] [Abstract][Full Text] [Related]
13. Castleman's disease with renal infiltration by polyclonal plasma cells.
Frøkjaer Thomsen O; Ladefoged J
Clin Nephrol; 1998 May; 49(5):328-30. PubMed ID: 9617500
[TBL] [Abstract][Full Text] [Related]
14. Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies.
Chilosi M; Menestrina F; Lestani M; Bonetti F; Scarpa A; Caligaris-Cappio F; Pizzolo G; Perini A; Fiore-Donati L
Histol Histopathol; 1987 Jan; 2(1):49-55. PubMed ID: 2980702
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous castleman's disease responds to anti interleukin-6 treatment.
Ahmed B; Tschen JA; Cohen PR; Zaki MH; Rady PL; Tyring SK; Corringham RE; Kurzrock R
Mol Cancer Ther; 2007 Sep; 6(9):2386-90. PubMed ID: 17766835
[TBL] [Abstract][Full Text] [Related]
16. Nodal marginal zone B-cell lymphoma resembling plasmacytoma arising from a plasma cell variant of localized Castleman's disease: a case report.
Kojima M; Nakamura S; Shimizu K; Suda Y; Kasuga Y; Sugihara S; Sakata N; Masawa N
APMIS; 2002 Aug; 110(7-8):523-7. PubMed ID: 12390409
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous Castleman's disease of the wrist.
Sleater J; Mullins D
Am J Dermatopathol; 1995 Apr; 17(2):174-8. PubMed ID: 8600784
[TBL] [Abstract][Full Text] [Related]
19. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype.
Harris NL; Bhan AK
Am J Surg Pathol; 1987 Feb; 11(2):109-13. PubMed ID: 3544885
[TBL] [Abstract][Full Text] [Related]
20. IgG4-related disorder of the retroperitoneum resembling Castleman's disease plasma cell type: a report of 2 cases.
Kojima M; Nakamura N; Motoori T; Shimizu K; Haratake J; Nakamura S
Int J Surg Pathol; 2011 Apr; 19(2):220-4. PubMed ID: 19372084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
